Doctors Of Bellevue-Redmond

10/24/2025

NOVEMBER 14, 2025 ENENT

At Doctors of Bellevue Redmond, we believe prevention and early detection are key to achieving your best health. 💪

This Pancreatic Cancer Awareness Month, we’re excited to partner with Grail to offer the Galleri multi-cancer early detection blood test — right here in our office!

Join us for a special event on November 14th, where you can get screened at a discounted rate. The Galleri test can detect 50+ types of cancer (many that don’t have standard screenings yet) — all with a simple blood draw.

Spots are limited — click here to register 👉 https://go.oncehub.com/DoctorsofBelRed

05/29/2025

A healthy diet is about balance, not restriction.
Eat more whole foods—fruits, veggies, whole grains, lean proteins, and healthy fats.
Drink water. Cut back on sugar and processed foods.
Small, consistent choices lead to lasting health.

05/26/2025

Our provider: Yelena Brukhis, PA

05/26/2025

Our provider: Robert Olberg, PA

03/10/2025

Are you listening to your heart? ❤️

Heart disease is the leading cause of death for women, yet many don’t recognize the warning signs of a heart attack. Symptoms in women can be different from men and may include:

⚠️ Unusual fatigue
⚠️ Shortness of breath
⚠️ Nausea or dizziness
⚠️ Chest discomfort (not always severe)
⚠️ Pain in the neck, jaw, back, or arms

February is American Heart Month, a time to focus on women’s heart health. Take care of your heart—know the risks, recognize the signs, and schedule a check-up with our providers today!

📍 same-day appointments available for urgent visits
📞 Call: 425-208-0026

Would you like any edits or additional details? Also, do you want me to design an Instagram post similar to the one you shared?

02/15/2025

02/14/2025

Weight loss injection information.

About Tirzepatide / Niacinamide Injection

Tirzepatide
Tirzepatide functions as a dual GLP-1 and GIP agonist. Similar to other GLP-1 medicines, it is currently used as a second-line diabetic treatment and administered as a once-weekly subcutaneous injection.

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. It has not been tested on individuals with pancreatitis and is not approved to treat type-1 diabetes mellitus. As a GIP and GLP-1 receptor agonist, it is implemented as a second-line defense against type 2 diabetes for glycemic control and significantly reduces body weight.

According to recent clinical studies, tirzepatide decreases hemoglobin A1C levels more effectively than a placebo. In comparison to -0.86% with placebo, the SURPASS-5 clinical trial revealed a -2.11% drop in hemoglobin A1C levels at 5mg per week dose. Hemoglobin A1C decreased by -2.34% when tirzepatide was taken at the maximum dose of 15 mg per week. This was proven during a 40-week period. With a tirzepatide dosage of 5 mg, a weight loss of 5.4 kg was observed, while a weight loss of 10.5 kg was observed with a dosage of 15 mg. A popular GLP-1 drug used for weight loss therapy is similar to this dose-dependent link with weight loss.

Tirzepatide has been demonstrated to function similarly to GLP-1 medicines but more effectively. Given its ability to help people lose weight and absence of liver toxicity, it could help people with non-alcoholic fatty liver disease (NAFLD) in a secondary way.

Niacinamide

Niacin, also known as nicotinic acid or vitamin B3, is a vital water-soluble B vitamin that may play a crucial role in various physiological functions. It may help support the metabolism of carbohydrates, fats, and proteins, facilitating the conversion of food into energy. Niacin may also help support healthy skin, nerves, and digestive systems.

To schedule a consultation and or to start the treatment please call us at 425-208-0026.